Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT04875858
Eligibility Criteria:
Inclusion Criteria
* Elderly people aged 70-75 years
* Had received PPSV23 in the previous 5-7 years
Exclusion Criteria:
* Immunocompromised patients
* Subjects receiving immunosuppressive agents
* Subjects with a history of vaccination with pneumococcal conjugate vaccine
* Subjects with a history of pneumococcal disease (positive culture from blood or other sterile fluid)
* Fever (defined as an oral temperature \>37.5℃) within 24 h before PPSV23 vaccination
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
70 Years
Maximum Age:
75 Years
Study:
NCT04875858
Study Brief:
Protocol Section:
NCT04875858